Nasocalm
Sodium Chloride (NaCl) · SODIUM CHLORIDE .9 mg/100mg · Solution · Nasal · Virexion Health Inc.
NDC 85436-0002-01 · 60 VIAL in 1 BOX / 5 mg in 1 VIAL · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
OAI inspection at a producing facility (24 months) · sole-source market · 1 Class I/II recall(s) in 12 months
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- M016
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Sodium Chloride (NaCl) (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Virexion Health Inc. | SODIUM CHLORIDE .9 mg/100mg | Jul 15, 2026 | Jul 29, 2026 |
| Virexion Health Inc. | SODIUM CHLORIDE 3 mg/100mg | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Nasocalm — NDC 85436-0002-01," retrieved September 3, 2026, https://drugdashboards.com/drug/85436000201.
Free to cite with attribution — see how the data is put together.